Preface
Magnetic resonance imaging in prostate cancer
Translational Andrology and Urology
2017;
6
(3)
:343-344
.
(23 June 2017)
Review Article
Cost consideration in utilization of multiparametric magnetic resonance imaging in prostate cancer
Translational Andrology and Urology
2017;
6
(3)
:345-354
.
(23 June 2017)
Standards for MRI reporting—the evolution to PI-RADS v 2.0
Translational Andrology and Urology
2017;
6
(3)
:355-367
.
(23 June 2017)
Transperineal vs. transrectal biopsy in MRI targeting
Translational Andrology and Urology
2017;
6
(3)
:368-375
.
(23 June 2017)
Multiparametric magnetic resonance imaging of the prostate—a basic tutorial
Translational Andrology and Urology
2017;
6
(3)
:376-386
.
(23 June 2017)
Pre-biopsy MRI as an adjunct for cancer detection in men with elevated PSA and no previous biopsy
Translational Andrology and Urology
2017;
6
(3)
:387-394
.
(23 June 2017)
Direct magnetic resonance imaging-guided biopsy of the prostate: lessons learned in establishing a regional referral center
Translational Andrology and Urology
2017;
6
(3)
:395-405
.
(23 June 2017)
Co-registration of MRI and ultrasound: accuracy of targeting based on radiology-pathology correlation
Translational Andrology and Urology
2017;
6
(3)
:406-412
.
(23 June 2017)
Positron emission tomography (PET) in primary prostate cancer staging and risk assessment
Translational Andrology and Urology
2017;
6
(3)
:413-423
.
(23 June 2017)
Magnetic resonance imaging detection of prostate cancer in men with previous negative prostate biopsy
Translational Andrology and Urology
2017;
6
(3)
:424-431
.
(23 June 2017)
A critical comparison of techniques for MRI-targeted biopsy of the prostate
Translational Andrology and Urology
2017;
6
(3)
:432-443
.
(23 June 2017)
Role of prostate magnetic resonance imaging in active surveillance
Translational Andrology and Urology
2017;
6
(3)
:444-452
.
(23 June 2017)
Multi-parametric MRI imaging of the prostate—implications for focal therapy
Translational Andrology and Urology
2017;
6
(3)
:453-463
.
(23 June 2017)
Role of mpMRI of the prostate in screening for prostate cancer
Translational Andrology and Urology
2017;
6
(3)
:464-471
.
(23 June 2017)
Multi-parametric magnetic resonance imaging as a management decision tool
Translational Andrology and Urology
2017;
6
(3)
:472-482
.
(23 June 2017)
MRI-fusion biopsy: the contemporary experience
Translational Andrology and Urology
2017;
6
(3)
:483-489
.
(23 June 2017)
Diffusion weighted imaging of the prostate—principles, application, and advances
Translational Andrology and Urology
2017;
6
(3)
:490-498
.
(23 June 2017)
Is contrast enhancement needed for diagnostic prostate MRI?
Translational Andrology and Urology
2017;
6
(3)
:499-509
.
(23 June 2017)
Original Article
Buccal mucosal graft urethroplasty in men—risk factors for recurrence and complications: a third referral centre experience in anterior urethroplasty using buccal mucosal graft
Translational Andrology and Urology
2017;
6
(3)
:510-516
.
(23 June 2017)
Weekly ascorbic acid infusion in castration-resistant prostate cancer patients: a single-arm phase II trial
Translational Andrology and Urology
2017;
6
(3)
:517-528
.
(23 June 2017)
A prospective evaluation of penile measures and glans penis sensory changes after penile prosthetic surgery
Translational Andrology and Urology
2017;
6
(3)
:529-533
.
(23 June 2017)
Utility of trigger point injection as an adjunct to physical therapy in men with chronic prostatitis/chronic pelvic pain syndrome
Translational Andrology and Urology
2017;
6
(3)
:534-537
.
(23 June 2017)
Review Articles
Canine prostate models in preclinical studies of minimally invasive interventions: part I, canine prostate anatomy and prostate cancer models
Translational Andrology and Urology
2017;
6
(3)
:538-546
.
(23 June 2017)
Canine prostate models in preclinical studies of minimally invasive interventions: part II, benign prostatic hyperplasia models
Translational Andrology and Urology
2017;
6
(3)
:547-555
.
(23 June 2017)
Effects of metformin on endothelial health and erectile dysfunction
Translational Andrology and Urology
2017;
6
(3)
:556-565
.
(23 June 2017)
Endogenous and exogenous testosterone and prostate cancer: decreased-, increased- or null-risk?
Translational Andrology and Urology
2017;
6
(3)
:566-579
.
(23 June 2017)
Case Report
Penile fracture: role of ultrasound
Translational Andrology and Urology
2017;
6
(3)
:580-584
.
(23 June 2017)
Technical Note
Transrectal ultrasound-guided extraction of impacted prostatic urethral calculi: a simple alternative to endoscopy
Translational Andrology and Urology
2017;
6
(3)
:585-589
.
(23 June 2017)
Editorial
Emerging role of liquid biopsy of cell-free tumor DNA for bladder cancer surveillance
Translational Andrology and Urology
2017;
6
(3)
:590-592
.
(23 June 2017)
Early or delayed radiotherapy after prostatectomy—who really benefits?
Translational Andrology and Urology
2017;
6
(3)
:593-594
.
(23 June 2017)
Bridging the gap: use of scaffolding tissue bio-grafts to bolster vesicourethral anastomosis during salvage robot-assisted prostatectomy reduced leak rates and catheter times
Translational Andrology and Urology
2017;
6
(3)
:595-596
.
(23 June 2017)
Drugs for the overactive bladder: are there differences in persistence and compliance?
Translational Andrology and Urology
2017;
6
(3)
:597-601
.
(23 June 2017)
Long-term adherence to clinical therapy of overactive bladder
Translational Andrology and Urology
2017;
6
(3)
:602-603
.
(23 June 2017)
From PROMIS to PRO-MRI in primary prostate cancer diagnosis
Translational Andrology and Urology
2017;
6
(3)
:604-607
.
(23 June 2017)
Disclosure:
The focused issue “Magnetic Resonance Imaging in Prostate Cancer” was commissioned by the editorial office, Translational Andrology and Urology without any sponsorship or funding. Marc A. Bjurlin, Andrew B. Rosenkrantz, Herbert Lepor and Samir S. Taneja served as the unpaid Guest Editors for the focused issue.